Paul Schimmel - Apr 26, 2023 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
Director
Signature
/s/ Nancy E. Denyes, attorney-in-fact
Stock symbol
LIFE
Transactions as of
Apr 26, 2023
Transactions value $
$0
Form type
4
Date filed
4/28/2023, 04:54 PM
Previous filing
Apr 28, 2022
Next filing
May 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFE Common stock Options Exercise +6K +207.61% 8.89K Apr 26, 2023 Direct F1, F2
holding LIFE Common stock 113K Apr 26, 2023 See Footnote F3
holding LIFE Common stock 679K Apr 26, 2023 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIFE Restricted Stock Unit Options Exercise $0 -6K -100% $0.00* 0 Apr 26, 2023 Common Stock 6K Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022.
F2 RSUs convert into common stock on a one-for-one basis.
F3 These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel.
F4 These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.
F5 The RSUs fully vested one year from the grant date which was April 26, 2022.